Thomas J et al. |
The immunosuppressive action of FK506. In vitro induction of allogeneic unresponsiveness in human CTL precursors. |
1990 |
Transplantation |
pmid:1689518
|
David-Neto E et al. |
Longitudinal Pharmacokinetics of Everolimus When Combined With Low-level of Tacrolimus in Elderly Renal Transplant Recipients. |
2017 |
Transplantation |
pmid:27798513
|
Vathsala A et al. |
Analysis of the interactions of immunosuppressive drugs with cyclosporine in inhibiting DNA proliferation. |
1990 |
Transplantation |
pmid:1689520
|
Jain A et al. |
Pregnancy after liver transplantation under tacrolimus. |
1997 |
Transplantation |
pmid:9293865
|
Farid SG et al. |
Alemtuzumab (Campath-1H)-induced coagulopathy in renal transplantation. |
2009 |
Transplantation |
pmid:19502974
|
Garcia-Criado FJ et al. |
Tacrolimus (FK506) down-regulates free radical tissue levels, serum cytokines, and neutrophil infiltration after severe liver ischemia. |
1997 |
Transplantation |
pmid:9293871
|
Satterthwaite R et al. |
Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine. |
1998 |
Transplantation |
pmid:9484771
|
Stevens RB et al. |
Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report. |
2008 |
Transplantation |
pmid:18497677
|
Takaya S et al. |
The adverse impact on liver transplantation of using positive cytotoxic crossmatch donors. |
1992 |
Transplantation |
pmid:1371195
|
Francavilla A et al. |
Inhibition of liver, kidney, and intestine regeneration by rapamycin. |
1992 |
Transplantation |
pmid:1371198
|
Arns W et al. |
Pharmacokinetics and Clinical Outcomes of Generic Tacrolimus (Hexal) Versus Branded Tacrolimus in De Novo Kidney Transplant Patients: A Multicenter, Randomized Trial. |
2017 |
Transplantation |
pmid:28658202
|
Sheikh AM et al. |
Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels. |
1999 |
Transplantation |
pmid:10440408
|
Lawsin L and Light JA |
Severe acute renal failure after exposure to sirolimus-tacrolimus in two living donor kidney recipients. |
2003 |
Transplantation |
pmid:12544890
|
Furukawa H et al. |
Prolongation of canine liver allograft survival by a novel immunosuppressant, FTY720: effect of monotherapy and combined treatment with conventional drugs. |
2000 |
Transplantation |
pmid:10670633
|
Moxey-Mims MM |
Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506) |
1999 |
Transplantation |
pmid:10440413
|
Jordan ML et al. |
Results of pancreas transplantation after steroid withdrawal under tacrolimus immunosuppression. |
2000 |
Transplantation |
pmid:10670637
|
Hodge G et al. |
Lymphocytic bronchiolitis is associated with inadequate suppression of blood T-cell granzyme B, IFN-gamma, and TNF-alpha. |
2010 |
Transplantation |
pmid:20559033
|
Asako H et al. |
Reduction of leukocyte adherence and emigration by cyclosporine and L683,590 (FK506) in postcapillary venules. |
1992 |
Transplantation |
pmid:1384191
|
Yun J et al. |
Bilateral ischemic optic neuropathy in a patient using tacrolimus (FK506) after liver transplantation. |
2010 |
Transplantation |
pmid:20559109
|
Fujita T et al. |
Prolonged survival of rat skin allograft by treatment with FK506 ointment. |
1997 |
Transplantation |
pmid:9326422
|
Kato T et al. |
Rhabdomyolysis after kidney transplantation caused by elevated serum cyclosporine due to metabolic enzyme and transporters disorder. |
2011 |
Transplantation |
pmid:21747275
|
Pratschke J et al. |
Treatment of cyclosporine-related adverse effects by conversion to tacrolimus after liver transplantation. |
1997 |
Transplantation |
pmid:9326428
|
Ashokkumar C et al. |
Allospecific CD154+ T-cytotoxic memory cells identify recipients experiencing acute cellular rejection after renal transplantation. |
2011 |
Transplantation |
pmid:21747326
|
McGhee B et al. |
Therapeutic use of an extemporaneously prepared oral suspension of tacrolimus in pediatric patients. |
1997 |
Transplantation |
pmid:9326429
|
High KP |
The antimicrobial activities of cyclosporine, FK506, and rapamycin. |
1994 |
Transplantation |
pmid:7517076
|
Berenguer M et al. |
Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients. |
2010 |
Transplantation |
pmid:21068701
|
Cosio FG et al. |
Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsies. |
2007 |
Transplantation |
pmid:17318073
|
Yoshimura N et al. |
The direct effect of FK506 and rapamycin on interleukin 1(beta) and immunoglobulin production in vitro. |
1994 |
Transplantation |
pmid:7517078
|
Budde K et al. |
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes. |
2007 |
Transplantation |
pmid:17318074
|
Casey MJ et al. |
Prolonged immunosuppression preserves nonsensitization status after kidney transplant failure. |
2014 |
Transplantation |
pmid:24717218
|
Maes BD et al. |
Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors. |
2001 |
Transplantation |
pmid:11726827
|
Stifft F et al. |
Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation. |
2014 |
Transplantation |
pmid:24686426
|
Kahan BD |
An immunosuppressive triumvirate to minimize renal injuries associated with calcineurin antagonist therapy. |
1999 |
Transplantation |
pmid:10428260
|
Washburn K et al. |
Steroid elimination 24 hours after liver transplantation using daclizumab, tacrolimus, and mycophenolate mofetil. |
2001 |
Transplantation |
pmid:11726831
|
Toso C et al. |
Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients. |
2003 |
Transplantation |
pmid:14557767
|
Sampaio MS et al. |
Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients. |
2012 |
Transplantation |
pmid:22129761
|
Moxey-Mims MM et al. |
Increased incidence of insulin-dependent diabetes mellitus in pediatric renal transplant patients receiving tacrolimus (FK506) |
1998 |
Transplantation |
pmid:9521193
|
Vu MD et al. |
Combination therapy of malononitrilamide FK778 with tacrolimus on cell proliferation assays and in rats receiving renal allografts. |
2003 |
Transplantation |
pmid:12792496
|
Tzakis AG et al. |
Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation. |
2003 |
Transplantation |
pmid:12792506
|
Peloso LJ et al. |
The serum concentration of tacrolimus after ingesting omeprazole: a pilot study. |
2014 |
Transplantation |
pmid:25221905
|
Koenen HJ et al. |
Superior T-cell suppression by rapamycin and FK506 over rapamycin and cyclosporine A because of abrogated cytotoxic T-lymphocyte induction, impaired memory responses, and persistent apoptosis. |
2003 |
Transplantation |
pmid:12792519
|
Hytiroglou P et al. |
FK506 versus cyclosporine as primary immunosuppressive agent for orthotopic liver allograft recipients. Histologic and immunopathologic observations. |
1993 |
Transplantation |
pmid:7506452
|
Jain A et al. |
Pharmacokinetics of tacrolimus in living donor liver transplant and deceased donor liver transplant recipients. |
2008 |
Transplantation |
pmid:18347534
|
Gallon L et al. |
Differential Effects of Calcineurin and Mammalian Target of Rapamycin Inhibitors on Alloreactive Th1, Th17, and Regulatory T Cells. |
2015 |
Transplantation |
pmid:25905982
|
Castells L et al. |
Liver transplantation in HIV-HCV coinfected patients: a case-control study. |
2007 |
Transplantation |
pmid:17297413
|
Murase N et al. |
FK506 suppression of heart and liver allograft rejection. II: The induction of graft acceptance in rats. |
1990 |
Transplantation |
pmid:1700504
|
Alhamad T et al. |
Targeting High Calcineurin Inhibitor Levels After Acute Rejection With Less Tremor: A New Strategy. |
2017 |
Transplantation |
pmid:28422926
|
Robertsen I et al. |
Use of generic tacrolimus in elderly renal transplant recipients: precaution is needed. |
2015 |
Transplantation |
pmid:25148382
|
Koh A et al. |
Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients. |
2010 |
Transplantation |
pmid:20145529
|
Shapiro R et al. |
Pediatric renal transplantation under tacrolimus-based immunosuppression. |
1999 |
Transplantation |
pmid:10075598
|
Königsrainer A et al. |
Nonocclusive segmental mesenteric ischemia after combined pancreas kidney transplantation: mycophenolate mofetil as an etiological factor? |
2000 |
Transplantation |
pmid:10972233
|
Sofi AA et al. |
Bullous pemphigoid associated with acute renal allograft rejection. |
2010 |
Transplantation |
pmid:20145531
|
Kaplan B et al. |
Low bioavailability of cyclosporine microemulsion and tacrolimus in a small bowel transplant recipient: possible relationship to intestinal P-glycoprotein activity. |
1999 |
Transplantation |
pmid:10075604
|
Mor E et al. |
Reversal of severe FK506 side effects by conversion to cyclosporine-based immunosuppression. |
1994 |
Transplantation |
pmid:7519800
|
Merkle M et al. |
The effect of sevelamer on tacrolimus target levels. |
2005 |
Transplantation |
pmid:16177649
|
Erden E et al. |
Plasma FK506 levels in patients with histopathologically documented renal allograft rejection. |
1994 |
Transplantation |
pmid:7519801
|
McDevitt-Potter LM et al. |
A multicenter experience with generic tacrolimus conversion. |
2011 |
Transplantation |
pmid:21788920
|
Demmers MW et al. |
Substantial proliferation of human renal tubular epithelial cell-reactive CD4+CD28null memory T cells, which is resistant to tacrolimus and everolimus. |
2014 |
Transplantation |
pmid:24157471
|
Dickenmann MJ et al. |
Blood eosinophilia in tacrolimus-treated patients: an indicator of Pneumocystis carinii pneumonia. |
1999 |
Transplantation |
pmid:10589963
|
Eckhoff DE et al. |
Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation. |
1998 |
Transplantation |
pmid:9458011
|
Roth D et al. |
Primary immunosuppression with tacrolimus and mycophenolate mofetil for renal allograft recipients. |
1998 |
Transplantation |
pmid:9458023
|
Zhao W et al. |
Pharmacokinetic interaction between tacrolimus and amlodipine in a renal transplant child. |
2012 |
Transplantation |
pmid:22450597
|
Jacobson PA et al. |
Genetic and clinical determinants of early, acute calcineurin inhibitor-related nephrotoxicity: results from a kidney transplant consortium. |
2012 |
Transplantation |
pmid:22334041
|
Schneeberger S et al. |
Cytomegalovirus-related complications in human hand transplantation. |
2005 |
Transplantation |
pmid:16123716
|
Ciancio G et al. |
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring. |
2005 |
Transplantation |
pmid:16123718
|
Thorp M et al. |
The effect of conversion from cyclosporine to tacrolimus on gingival hyperplasia, hirsutism and cholesterol. |
2000 |
Transplantation |
pmid:10762229
|
Murase N et al. |
Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. |
1993 |
Transplantation |
pmid:7682735
|
Sulanc E et al. |
New-onset diabetes after kidney transplantation: an application of 2003 International Guidelines. |
2005 |
Transplantation |
pmid:16249743
|
Laskow DA et al. |
An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group. |
1996 |
Transplantation |
pmid:8878381
|
Mourad M et al. |
Sirolimus and tacrolimus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids. |
2005 |
Transplantation |
pmid:16249748
|
Woodle ES et al. |
Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies. |
1996 |
Transplantation |
pmid:8878382
|
Macedo C et al. |
Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantation. |
2012 |
Transplantation |
pmid:22343334
|
Tanaka A et al. |
Living related liver transplantation across ABO blood groups. |
1994 |
Transplantation |
pmid:7522363
|
Klein IH et al. |
Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects. |
2002 |
Transplantation |
pmid:11907418
|
Vincenti F et al. |
A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years. |
2002 |
Transplantation |
pmid:11907427
|
Ringe B et al. |
A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil. |
2001 |
Transplantation |
pmid:11258429
|
Beckebaum S et al. |
Predictive factors of outcome in patients transplanted for hepatitis B. |
2009 |
Transplantation |
pmid:19300191
|
Higgins R et al. |
Rises and falls in donor-specific and third-party HLA antibody levels after antibody incompatible transplantation. |
2009 |
Transplantation |
pmid:19300192
|
Singh N et al. |
Infectious complications in liver transplant recipients on tacrolimus. Prospective analysis of 88 consecutive liver transplants. |
1994 |
Transplantation |
pmid:7524204
|
Pascual J et al. |
Authors' reply: cyclosporine A versus tacrolimus in steroid withdrawal strategies. |
2011 |
Transplantation |
pmid:21336083
|
Steiner RW |
Steroid withdrawal in kidney transplantation: the subgroup fallacy. |
2011 |
Transplantation |
pmid:21336084
|
McCarthy SA et al. |
The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. |
1992 |
Transplantation |
pmid:1384186
|
Dhar DK et al. |
The salutary effect of FK506 in ischemia-reperfusion injury of the canine liver. |
1992 |
Transplantation |
pmid:1384188
|
Bashuda H et al. |
Induction of persistent allograft tolerance in the rat by combined treatment with anti-leukocyte function-associated antigen-1 and anti-intercellular adhesion molecule-1 monoclonal antibodies, donor-specific transfusion, and FK506. |
1996 |
Transplantation |
pmid:8693525
|
Nakajima K et al. |
Prolongation of cardiac xenograft survival in rats treated with 15-deoxyspergualin alone and in combination with FK506. |
1988 |
Transplantation |
pmid:2454521
|
Konrad T et al. |
Regulation of glucose tolerance in patients after liver transplantation: impact of cyclosporin versus tacrolimus therapy. |
2000 |
Transplantation |
pmid:10852599
|
Fredericks S and Holt DW |
TGF-beta quantitation can be tricky. |
1999 |
Transplantation |
pmid:10480399
|
Schvarcz R et al. |
Interaction between nelfinavir and tacrolimus after orthoptic liver transplantation in a patient coinfected with HIV and hepatitis C virus (HCV). |
2000 |
Transplantation |
pmid:10852623
|
Hughes JR et al. |
Blood levels of TGFbeta1 in liver transplant recipients receiving either tacrolimus or micro-emulsified cyclosporine. |
1999 |
Transplantation |
pmid:10480422
|
Ellis D et al. |
Phospholipase-C and Na-K ATPase activation by cyclosporine and FK506 in LLC-PK1, cells. Possible implications in blood pressure regulation. |
1991 |
Transplantation |
pmid:1714643
|
Cacciarelli TV et al. |
Management of posttransplant lymphoproliferative disease in pediatric liver transplant recipients receiving primary tacrolimus (FK506) therapy. |
1998 |
Transplantation |
pmid:9808490
|
Macphee IA et al. |
Tacrolimus pharmacogenetics: the CYP3A5*1 allele predicts low dose-normalized tacrolimus blood concentrations in whites and South Asians. |
2005 |
Transplantation |
pmid:15729180
|
Letavernier E et al. |
Proteinuria following a switch from calcineurin inhibitors to sirolimus. |
2005 |
Transplantation |
pmid:16314786
|
Baggio B et al. |
Relationship between plasma phospholipid polyunsaturated fatty acid composition and bone disease in renal transplantation. |
2005 |
Transplantation |
pmid:16314806
|
Wai LE et al. |
Rapamycin, but not cyclosporine or FK506, alters natural killer cell function. |
2008 |
Transplantation |
pmid:18192925
|
Herold KC et al. |
Inhibition of glucose-stimulated insulin release from beta TC3 cells and rodent islets by an analog of FK506. |
1993 |
Transplantation |
pmid:7678356
|
Holman MJ et al. |
FK506-associated thrombotic thrombocytopenic purpura. |
1993 |
Transplantation |
pmid:7678357
|
Todo S et al. |
Small intestinal transplantation in humans with or without the colon. |
1994 |
Transplantation |
pmid:7512291
|
Griffith BP et al. |
A prospective randomized trial of FK506 versus cyclosporine after human pulmonary transplantation. |
1994 |
Transplantation |
pmid:7512292
|
Sun S et al. |
Effect of tacrolimus on hemodynamics and absorption of experimental small intestinal transplants. |
1996 |
Transplantation |
pmid:8633368
|